-
Something wrong with this record ?
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics
I. Kimura, D. Yamasoba, H. Nasser, H. Ito, J. Zahradnik, J. Wu, S. Fujita, K. Uriu, J. Sasaki, T. Tamura, R. Suzuki, S. Deguchi, A. Plianchaisuk, K. Yoshimatsu, Y. Kazuma, S. Mitoma, G. Schreiber, H. Asakura, M. Nagashima, K. Sadamasu, K....
Language English Country United States
Document type Journal Article
Grant support
JP223fa627001
Japan Agency for Medical Research and Development (AMED)
JP223fa727002
Japan Agency for Medical Research and Development (AMED)
JP223fa627009
Japan Agency for Medical Research and Development (AMED)
JP22fk0108511
Japan Agency for Medical Research and Development (AMED)
JP22fk0108516
Japan Agency for Medical Research and Development (AMED)
JP22fk0108506
Japan Agency for Medical Research and Development (AMED)
JP22fk0108146
Japan Agency for Medical Research and Development (AMED)
JP21fk0108494
Japan Agency for Medical Research and Development (AMED)
JP21fk0108425
Japan Agency for Medical Research and Development (AMED)
JP21fk0108432
Japan Agency for Medical Research and Development (AMED)
JP21fk0108465
Japan Agency for Medical Research and Development (AMED)
JP21fk0108493
Japan Agency for Medical Research and Development (AMED)
JP22fk0108516
Japan Agency for Medical Research and Development (AMED)
JP21fk0108574
Japan Agency for Medical Research and Development (AMED)
JP22fk0108617
Japan Agency for Medical Research and Development (AMED)
JP22fk0410033
Japan Agency for Medical Research and Development (AMED)
JP22fk0410039
Japan Agency for Medical Research and Development (AMED)
JP22fk0410047
Japan Agency for Medical Research and Development (AMED)
JP22fk0410055
Japan Agency for Medical Research and Development (AMED)
JP23fk0410047
Japan Agency for Medical Research and Development (AMED)
JP23fk0410056
Japan Agency for Medical Research and Development (AMED)
JP23fk0410058
Japan Agency for Medical Research and Development (AMED)
JP22jk0210039
Japan Agency for Medical Research and Development (AMED)
JP22wm0325009
Japan Agency for Medical Research and Development (AMED)
CREST JP21gm1610005
Japan Agency for Medical Research and Development (AMED)
CREST JP22gm1610008
Japan Agency for Medical Research and Development (AMED)
PRESTO JPMJPR22R1
Japan Science an Technology Agency (JST)
CREST JPMJCR20H4
Japan Science an Technology Agency (JST)
CREST JPMJCR20H6
Japan Science an Technology Agency (JST)
CREST JPMJCR20H8
Japan Science an Technology Agency (JST)
SPRING JPMJSP2108
Japan Science an Technology Agency (JST)
KAKENHI 20K15767
Japan Society for the Promotion of Science (JSPS)
KAKENHI 23K14526
Japan Society for the Promotion of Science (JSPS)
JPJSCCA20190008
Japan Society for the Promotion of Science (JSPS)
KAKENHI 20H05773
Japan Society for the Promotion of Science (JSPS)
KAKENHI 21H02736
Japan Society for the Promotion of Science (JSPS)
KAKENHI 22K07103
Japan Society for the Promotion of Science (JSPS)
KAKENHI 22K16375
Japan Society for the Promotion of Science (JSPS)
DC2 22J11578
Japan Society for the Promotion of Science (JSPS)
JSPS Leading Initiative for Excellent Young Researchers (LEADER); number has not been assigned
Japan Society for the Promotion of Science (JSPS)
Takeda Science Foundation
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Naito Foundation
Shin-Nihon Foundation of Advanced Medical Research
Waksman Foundation of Japan
Intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE)
Ito Foundation Research Grant
International Joint Research Project of the Institute of Medical Science, the University of Tokyo
LX22NPO5103
European Union, Next Generation EU
NLK
Free Medical Journals
from 1967 to 6 months ago
Freely Accessible Science Journals
from 1967 to 6 months ago
PubMed Central
from 1967 to 1 year ago
Europe PubMed Central
from 1967 to 6 months ago
Open Access Digital Library
from 1967-02-01
Open Access Digital Library
from 1967-02-01
PubMed
37796123
DOI
10.1128/jvi.01011-23
Knihovny.cz E-resources
- MeSH
- COVID-19 * MeSH
- Spike Glycoprotein, Coronavirus genetics MeSH
- Humans MeSH
- Mutation MeSH
- SARS-CoV-2 genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Most studies investigating the characteristics of emerging SARS-CoV-2 variants have been focusing on mutations in the spike proteins that affect viral infectivity, fusogenicity, and pathogenicity. However, few studies have addressed how naturally occurring mutations in the non-spike regions of the SARS-CoV-2 genome impact virological properties. In this study, we proved that multiple SARS-CoV-2 Omicron BA.2 mutations, one in the spike protein and another downstream of the spike gene, orchestrally characterize this variant, shedding light on the importance of Omicron BA.2 mutations out of the spike protein.
1st Medical Faculty at Biocev Charles University Vestec Prague Czechia
AMED CREST Japan Agency for Medical Research and Development Tokyo Japan
Bioinformation and DDBJ Center National Institute of Genetics Mishima Japan
Center for Animal Disease Control University of Miyazaki Miyazaki Japan
Center for iPS Cell Research and Application Kyoto University Kyoto Japan
CREST Japan Science and Technology Agency Saitama Japan
Department of Biomolecular Sciences Weizmann Institute of Science Rehovot Israel
Department of Clinical Pathology Faculty of Medicine Suez Canal University Ismailia Egypt
Department of Hematology and Oncology Graduate School of Medicine Kyoto University Kyoto Japan
Department of Microbiology and Immunology Faculty of Medicine Hokkaido University Sapporo Japan
Department of Molecular Life Science Tokai University School of Medicine Isehara Japan
Department of Veterinary Science Faculty of Agriculture University of Miyazaki Miyazaki Japan
Faculty of Medicine Kobe University Kobe Japan
Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
Graduate School of Frontier Sciences The University of Tokyo Kashiwa Japan
Graduate School of Medicine and Veterinary Medicine University of Miyazaki Miyazaki Japan
Graduate School of Medicine The University of Tokyo Tokyo Japan
Institute for Genetic Medicine Hokkaido University Sapporo Japan
Institute for Vaccine Research and Development Hokkaido University Sapporo Japan
Laboratory of Medical Virology Institute for Life and Medical Sciences Kyoto University Kyoto Japan
Laboratory of Virus Control Research Institute for Microbial Diseases Osaka University Suita Japan
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000960
- 003
- CZ-PrNML
- 005
- 20240213093526.0
- 007
- ta
- 008
- 240109s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/jvi.01011-23 $2 doi
- 035 __
- $a (PubMed)37796123
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kimura, Izumi $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
- 245 10
- $a Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics / $c I. Kimura, D. Yamasoba, H. Nasser, H. Ito, J. Zahradnik, J. Wu, S. Fujita, K. Uriu, J. Sasaki, T. Tamura, R. Suzuki, S. Deguchi, A. Plianchaisuk, K. Yoshimatsu, Y. Kazuma, S. Mitoma, G. Schreiber, H. Asakura, M. Nagashima, K. Sadamasu, K. Yoshimura, A. Takaori-Kondo, Genotype to Phenotype Japan (G2P-Japan) Consortium, J. Ito, K. Shirakawa, K. Takayama, T. Irie, T. Hashiguchi, S. Nakagawa, T. Fukuhara, A. Saito, T. Ikeda, K. Sato
- 520 9_
- $a Most studies investigating the characteristics of emerging SARS-CoV-2 variants have been focusing on mutations in the spike proteins that affect viral infectivity, fusogenicity, and pathogenicity. However, few studies have addressed how naturally occurring mutations in the non-spike regions of the SARS-CoV-2 genome impact virological properties. In this study, we proved that multiple SARS-CoV-2 Omicron BA.2 mutations, one in the spike protein and another downstream of the spike gene, orchestrally characterize this variant, shedding light on the importance of Omicron BA.2 mutations out of the spike protein.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a COVID-19 $7 D000086382
- 650 _2
- $a SARS-CoV-2 $x genetika $7 D000086402
- 650 _2
- $a glykoprotein S, koronavirus $x genetika $7 D064370
- 650 _2
- $a mutace $7 D009154
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Yamasoba, Daichi $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u Faculty of Medicine, Kobe University , Kobe, Japan
- 700 1_
- $a Nasser, Hesham $u Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University , Kumamoto, Japan $u Department of Clinical Pathology, Faculty of Medicine, Suez Canal University , Ismailia, Egypt
- 700 1_
- $a Ito, Hayato $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan
- 700 1_
- $a Zahradnik, Jiri $u Department of Biomolecular Sciences, Weizmann Institute of Science , Rehovot, Israel $u First Medical Faculty at Biocev, Charles University , Vestec-Prague, Czechia
- 700 1_
- $a Wu, Jiaqi $u Department of Molecular Life Science, Tokai University School of Medicine , Isehara, Japan
- 700 1_
- $a Fujita, Shigeru $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u Graduate School of Medicine, The University of Tokyo , Tokyo, Japan
- 700 1_
- $a Uriu, Keiya $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u Graduate School of Medicine, The University of Tokyo , Tokyo, Japan
- 700 1_
- $a Sasaki, Jiei $u Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University , Kyoto, Japan
- 700 1_
- $a Tamura, Tomokazu $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan $u Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University , Sapporo, Japan $1 https://orcid.org/0000000313956610
- 700 1_
- $a Suzuki, Rigel $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan $u Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University , Sapporo, Japan
- 700 1_
- $a Deguchi, Sayaka $u Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, Japan
- 700 1_
- $a Plianchaisuk, Arnon $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
- 700 1_
- $a Yoshimatsu, Kumiko $u Institute for Genetic Medicine, Hokkaido University , Sapporo, Japan
- 700 1_
- $a Kazuma, Yasuhiro $u Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University , Kyoto, Japan
- 700 1_
- $a Mitoma, Shuya $u Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki , Miyazaki, Japan $u Graduate School of Medicine and Veterinary Medicine, University of Miyazaki , Miyazaki, Japan
- 700 1_
- $a Schreiber, Gideon $u Department of Biomolecular Sciences, Weizmann Institute of Science , Rehovot, Israel $1 https://orcid.org/0000000229225882
- 700 1_
- $a Asakura, Hiroyuki $u Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
- 700 1_
- $a Nagashima, Mami $u Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
- 700 1_
- $a Sadamasu, Kenji $u Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
- 700 1_
- $a Yoshimura, Kazuhisa $u Tokyo Metropolitan Institute of Public Health , Tokyo, Japan
- 700 1_
- $a Takaori-Kondo, Akifumi $u Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University , Kyoto, Japan
- 700 1_
- $a Ito, Jumpei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan
- 700 1_
- $a Shirakawa, Kotaro $u Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University , Kyoto, Japan $1 https://orcid.org/0000000274691276
- 700 1_
- $a Takayama, Kazuo $u Center for iPS Cell Research and Application (CiRA), Kyoto University , Kyoto, Japan $u AMED-CREST, Japan Agency for Medical Research and Development (AMED) , Tokyo, Japan $1 https://orcid.org/0000000211322457
- 700 1_
- $a Irie, Takashi $u Graduate School of Biomedical and Health Sciences, Hiroshima University , Hiroshima, Japan $1 https://orcid.org/0000000337658482
- 700 1_
- $a Hashiguchi, Takao $u Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University , Kyoto, Japan $1 https://orcid.org/0000000175787571
- 700 1_
- $a Nakagawa, So $u Department of Molecular Life Science, Tokai University School of Medicine , Isehara, Japan $u CREST, Japan Science and Technology Agency , Saitama, Japan $u Bioinformation and DDBJ Center, National Institute of Genetics , Mishima, Japan $1 https://orcid.org/0000000317603839
- 700 1_
- $a Fukuhara, Takasuke $u Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University , Sapporo, Japan $u Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University , Sapporo, Japan $u AMED-CREST, Japan Agency for Medical Research and Development (AMED) , Tokyo, Japan $u Laboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University , Suita, Japan $1 https://orcid.org/0000000154718331
- 700 1_
- $a Saito, Akatsuki $u Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki , Miyazaki, Japan $u Graduate School of Medicine and Veterinary Medicine, University of Miyazaki , Miyazaki, Japan $u Center for Animal Disease Control, University of Miyazaki , Miyazaki, Japan $1 https://orcid.org/0000000227924399
- 700 1_
- $a Ikeda, Terumasa $u Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University , Kumamoto, Japan $1 https://orcid.org/0000000328699450
- 700 1_
- $a Sato, Kei $u Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u Graduate School of Medicine, The University of Tokyo , Tokyo, Japan $u International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u CREST, Japan Science and Technology Agency , Saitama, Japan $u International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo , Tokyo, Japan $u Graduate School of Frontier Sciences, The University of Tokyo , Kashiwa, Japan $u Collaboration Unit for Infection, Joint Research Center for Human Retrovirus infection, Kumamoto University , Kumamoto, Japan $1 https://orcid.org/0000000344311380
- 710 2_
- $a Genotype to Phenotype Japan (G2P-Japan) Consortium
- 773 0_
- $w MED00003048 $t Journal of virology $x 1098-5514 $g Roč. 97, č. 10 (2023), s. e0101123
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37796123 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093523 $b ABA008
- 999 __
- $a ok $b bmc $g 2049533 $s 1210654
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 97 $c 10 $d e0101123 $e 20231005 $i 1098-5514 $m Journal of virology $n J Virol $x MED00003048
- GRA __
- $a JP223fa627001 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP223fa727002 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP223fa627009 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0108511 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0108516 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0108506 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0108146 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP21fk0108494 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP21fk0108425 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP21fk0108432 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP21fk0108465 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP21fk0108493 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0108516 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP21fk0108574 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0108617 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0410033 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0410039 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0410047 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22fk0410055 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP23fk0410047 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP23fk0410056 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP23fk0410058 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22jk0210039 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a JP22wm0325009 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a CREST JP21gm1610005 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a CREST JP22gm1610008 $p Japan Agency for Medical Research and Development (AMED)
- GRA __
- $a PRESTO JPMJPR22R1 $p Japan Science an Technology Agency (JST)
- GRA __
- $a CREST JPMJCR20H4 $p Japan Science an Technology Agency (JST)
- GRA __
- $a CREST JPMJCR20H6 $p Japan Science an Technology Agency (JST)
- GRA __
- $a CREST JPMJCR20H8 $p Japan Science an Technology Agency (JST)
- GRA __
- $a SPRING JPMJSP2108 $p Japan Science an Technology Agency (JST)
- GRA __
- $a KAKENHI 20K15767 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a KAKENHI 23K14526 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a JPJSCCA20190008 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a KAKENHI 20H05773 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a KAKENHI 21H02736 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a KAKENHI 22K07103 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a KAKENHI 22K16375 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a DC2 22J11578 $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $a JSPS Leading Initiative for Excellent Young Researchers (LEADER); number has not been assigned $p Japan Society for the Promotion of Science (JSPS)
- GRA __
- $p Takeda Science Foundation
- GRA __
- $p Mochida Memorial Foundation for Medical and Pharmaceutical Research
- GRA __
- $p Naito Foundation
- GRA __
- $p Shin-Nihon Foundation of Advanced Medical Research
- GRA __
- $p Waksman Foundation of Japan
- GRA __
- $p Intramural grant from Kumamoto University COVID-19 Research Projects (AMABIE)
- GRA __
- $p Ito Foundation Research Grant
- GRA __
- $p International Joint Research Project of the Institute of Medical Science, the University of Tokyo
- GRA __
- $a LX22NPO5103 $p European Union, Next Generation EU
- LZP __
- $a Pubmed-20240109